Proton Therapy Systems Market To Reach $1.2 Billion By 2030

Proton Therapy Systems Market Growth & Trends

The global proton therapy systems market size is expected to reach USD 1.2 billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030, according to a report by Grand View Research, Inc. The market is primarily driven by increasing number of proton therapy centers, rising number of cancer cases, and growing investments by hospitals to establish these centers.

Growing funds & investments by hospitals, manufacturers, and private investors are also contributing to the growth of this market. For instance, in August 2015, Mevion Medical Systems (U.S.) raised USD 200 million in an equity funding led by HOPU Investments (China) and YuanMing Capital (China). These funds are likely to be used for development of technologically advanced and low-cost products. Furthermore, governments across various geographies are including budgets for establishment of these centers. For instance, in July 2015, the state government of Victoria included nearly AUD 2 million (USD 1.53 million) to develop a National Centre for Proton Beam Therapy at the Victorian Comprehensive Cancer Centre (VCCC). The new center is expected to offer treatment to the patients in Australia.

In addition, rapid increase in the number of cancer cases globally is anticipated to bolster market growth during the forecast period. According to American Cancer Society, an estimated 1,688,780 new cancer cases are expected to be diagnosed in the U.S. and this disorder is likely to cause nearly 600,920 deaths in 2017. Furthermore, according to The Lancet, the number of women diagnosed with breast tumors is estimated to reach 3.2 million by 2030, which is almost double of 1.7 million in 2015.

Favorable reimbursement policies in the U.S and European countries and rising cancer-related healthcare expenditure in emerging nations is likely to propel the global proton therapy systems market. In addition, decreasing cost of proton therapy, increasing awareness, and rising adoption are expected to boost demand for these systems during the forecast period. However, high costs involved in the establishment of these centers and lack of reimbursement in emerging nations is likely to restrain growth in the coming years.

 Request a free sample copy or view report summary: Proton Therapy Systems Market Report

Proton Therapy Systems Market Report Highlights

• The equipment segment held majority of the revenue share in 2023 due to rise in the number of contracts for establishment of proton therapy centers

• The multi-room systems accounted for the largest market revenue share of 67.4% in 2030

• North America proton therapy systems market dominated in 2023 and accounted for the market share of 42.7%.

• Asia Pacific proton therapy systems market is estimated to register the fastest CAGR over the forecast period

Proton Therapy Systems Market Segmentation

Grand View Research has segmented the global proton therapy systems market report based on product, type, and region:

Proton Therapy Systems Product Outlook (Revenue, USD Million, 2018 - 2030)

• Equipment

• Services

Proton Therapy Systems Type Outlook (Revenue, USD Million, 2018 - 2030)

• Single-Room Systems

• Multi-Room Systems

Proton Therapy Systems Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

• Latin America

  • Brazil

• Middle East and Africa (MEA)

  • KSA

  • UAE

  • South Africa

List of Key Players of Proton Therapy Systems Market

• IBA Worldwide

• Optivus Proton Therapy, Inc.

• Mevion Medical Systems

• Advanced Oncotherapy plc

• Varian Medical Systems, Inc

• ProTom International, Inc

• Hitachi, Ltd.

• Mitsubishi Corporation

• ProNova Solutions, LLC

• Sumitomo Heavy Industries, Ltd